Column GROUP L P, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 409,140 shares at $4.84 ($2.0M) on 2023-01-10, disclosed to the SEC on 2023-01-12.
Open-market purchase of $2.0M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.84 | 100,070 | $484K | 24.7% |
| 2 | $4.84 | 100,070 | $484K | 24.7% |
| 3 | $4.76 | 209,000 | $995K | 50.7% |
| Total | $4.80 avg | 409,140 | $2.0M | 100% |
| Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |
| NGM | BUY | 2022-05-23 | $779K | — | Filing → |